Please reload

Recent Posts

Sexual abuse 'endemic' in aid sector, say MPs

July 31, 2018

1/10
Please reload

Featured Posts

Federal probe finds that just two drugs account for 90% of Medicaid rebate losses

January 3, 2018

Fierce Pharma ---------- After discovering that Mylan had avoided paying Medicaid tens of millions of dollars in rebates by misclassifying its EpiPen, Congress asked the agency to determine how wide-ranging the problem was. It now has its answer. The number of misclassified drugs is small, but the cost to the cash-strapped Medicaid program is big: hundreds of millions of dollars a year, and most of that comes from just a few drugs. While only 3% of the 30,000 drugs reviewed were misclassified, the report found that the cost to Medicaid for the 10 potentially misclassified drugs with the highest total reimbursement, ran to $1.3 billion between 2012 and 2016. To learn more click on the picture below to read the article.

 

 

Share on Facebook
Share on Twitter
Please reload

Follow Us

I'm busy working on my blog posts. Watch this space!

Please reload

Search By Tags
Please reload

Archive
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

© 2020 Safi Bello A Girls How To Guide